Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) in the United States (U.S.)
Not yet recruiting
ViiV Healthcare
Phase 4
2021-10-29
GLACIER (Giving Long Acting CABENUVA in an Infusion centER) is an interventional study
examining the administration of CABENUVA (Cabotegravir long acting [LA] plus Rilpivirine LA)
intramuscular (IM) in infusion centers in South-eastern United States. In this study, the
intervention is the process of using an infusion center as the location to receive the
CABENUVA IM injections. The acceptability and feasibility of the IC to deliver CABENUVA IM
injections will be assessed from the perspectives of the participants, HIV care providers and
IC staff. In this study, Month 1 is the Baseline visit.
CABENUVA is a registered trademark of ViiV Healthcare.
A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA
Not yet recruiting
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase 3
2023-01-01
The purpose of this study is to evaluate the efficacy and safety of CABENUVA (Long-acting
Cabotegravir Plus Long-acting Rilpivirine) in patients with HIV infection and severe renal
impairment. This study is considered research and is voluntary.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
